Skip to content

When you choose to publish with PLOS, your research makes an impact. Make your work accessible to all, without restrictions, and accelerate scientific discovery with options like preprints and published peer review that make your work more Open.

PLOS BLOGS PLOS Biologue

Remembering Barbara Cohen’s Impact on Scientific Publishing

Image caption: Barbara Cohen, a founding editor of PLOS, died on October 21, 2024, in Asturias, Spain (photo credit: Sandra Aamodt).

About the author: Hemai Parthasarathy is an entrepreneurial scientist, who most recently directed the Rapid Evaluation team at Alphabet’s innovation lab, X (formerly Google [X]).  Previously, Hemai was a founding editor at PLOS and Managing Editor of PLOS Biology.

I tell people that leaving Nature to join the founding team of PLOS in 2003 was a no-brainer. Open access to the scientific literature, reinventing scientific communication in the internet age… of course! Important and (still) worthy goals. Motivation, however, is usually a little more complicated and it’s often a little more personal. The facts are that, one day, I got a call from Barbara Cohen, my former colleague at Nature Publishing Group. She had been recruited by the PLOS founders to build a publishing organization and they were trying to round out the editorial team. Did I want to join them? Did I ?? Barbara tapping me on the shoulder, inviting me to join her in a new (ad)venture was reason enough to do almost anything.

Barbara first entered the publishing world in 1994 as an editor on Nature’s biology team, having completed a Ph.D. in genetics and an EMBO postdoctoral fellowship. She rose quickly to become the Editor of Nature Genetics in 1997.

Kevin Davies, the founding editor of Nature Genetics, credits Barbara with stamping her own vision on the journal in its subsequent 3+ years, broadening its scope considerably from human genetics to include outstanding work in developmental biology and other fields (see also: Nature, genetics and the Niven factor | Nature Genetics). Her Nature Genetics colleague, Bette Phimister, adds, “I am grateful for her influence on me, the journal, and the field of genetics. She expertly and enthusiastically identified and dissected areas of uncertainty (genetic loci for complex traits, for example) and then implemented measures to reduce them.”

PLOS colleague Mark Patterson recalls first meeting Barbara at a Nature Genetics microarray conference in Scottsdale, Arizona, in 1999, where she gave the welcoming address (see also: Chips around the world: Proceedings from the Nature Genetics Microarray Meeting | Physiological Genomics). “What an impressive, inspiring figure she cut. She was editor of the sponsoring journal, which had presumably underwritten a lot of the cost, but she almost laid out a challenge to the audience, minimizing her role: ‘It’s your conference. Make the most of it!’”

Barbara was all about challenging – and simultaneously supporting – colleagues to be their best selves and make the most of opportunities. Bette recalls Barbara encouraging her to accept a conference invitation in Naples at a time when Nature Genetics could ill afford absences from the office. “You have to go,” Barbara told her. “Naples is amazing!”

Barbara left Nature Publishing Group in 2000, reappearing as the inaugural Executive Editor of the Journal of Clinical Investigations in 2001. JCI espoused free online access to its content ahead of many of its peers (see also: JCI – A mission statement for the JCI at the dawn of the 21st century) and was a natural prelude to PLOS, which she joined in 2003 to fully champion the cause of open-access publishing in service of the scientific community.

“I only really got to know Barbara when we worked together to establish PLOS as a publisher,” says Vivian Siegel. “I remember sitting together with her and the rest of the founding team to think about editorial standards. She suggested we establish a “no scooping” policy, understanding before many others how critical it is for multiple research groups to come independently to the same conclusion, and how racing to be first only undermined scientific quality.” A de facto editorial guideline from the beginning, that policy was made official fifteen years later (See: The importance of being second | PLOS Biology).

Barbara gave the same energy to details as she did to the big-picture decisions. Vivian offers as example: “She came to me to discuss a decision on one of the early submissions to PLOS Biology. The paper showed two proteins interacting with each other using co-immunoprecipitation (co-IP), but had a precipitating antibody in one direction and not the other. The reviewers and academic editor pointed out that the paper would be stronger if they could do the co-IP in both directions. Together we puzzled out the possible outcomes of this request, including the authors spending many months trying and unable to get a precipitating antibody. We realized we would publish the paper anyway – and that therefore it wasn’t right to delay publication for something that wasn’t going to change our decision. Instead, Barbara would let them know that if they do get the co-IP to work in the other direction, we could add that as an addendum to the paper.”

Even as we were all working furiously to launch PLOS Biology in October 2003, Barbara was already also knee deep in PLOS Medicine, which was scheduled to launch the following year. As Mark says, “No challenge was too great for her. I thought: Medicine is such a different world than basic research, I wouldn’t have a clue! But, she just went for it and, as always, rose brilliantly to the challenge.” I attended a dinner for PLOS Medicine, which Barbara convened just after the launch of PLOS Biology in which the key questions for the journal were discussed among noted clinicians. Everything was on the table from scope and editorial model to outreach strategies.

“Barbara, an editorial leader in her own right, created a culture of collaboration and shared decision making,” says Vivian. “She expressed no need to be recognized as ‘the’ leader of a group, promoting and backing others to take those roles as they arose.”

Barbara spearheaded the effort to launch PLOS Medicine from the outset with her singular enthusiasm and passion to create a new kind of a truly international, open-access medical journal “that is both scientifically rigorous and compassionate” (see: PLoS Medicine | PLOS Biology). Also true to form, she recognized the need to recruit an editor to lead PLOS Medicine, who came from that community.

That editor, Ginny Barbour, remembers meeting Barbara when she interviewed to be one of the inaugural editors at PLOS Medicine. “It was a very unusual interview! She led me on a high speed walking tour of San Francisco, talking nonstop for about six hours, up and down the San Francisco hills. In retrospect, it was a highly appropriate introduction to working at PLOS – which was also high speed, intense and required stamina! What we aimed to do at PLOS Medicine required overwhelming belief in the mission and a ferocious work ethic. Barbara had both of those and inspired others too.”

Ultimately, as Executive Editor for the PLOS journals, Barbara made critical contributions across the portfolio, including to the community journals and PLOS ONE. She took on the thorny problems of consistency and integrity in editorial decision making wherever they arose, and led new initiatives to improve the publication process. (see: “Simple Rules for Editors”? Here Is One Rule to Tackle Neglected Problems of Publishing: Response from PLoS | PLOS Computational Biology). As Managing Editor of PLOS Biology, I always knew that she had my back when unexpected issues with authors, reviewers and published papers arose.

Liza Gross, who took on the essential work of translating PLOS content for lay audiences, without herself having a scientific background, says: “Barbara was such a generous and enthusiastic mentor for me, never tiring of my constant stream of questions about technical terminology, research techniques, what authors were trying to understand and how to think about the significance of results.”

The last time I saw Barbara was when I visited her farm in Asturias, Spain, last spring. She had traded in her post-PLOS seafaring lifestyle (sailing a 52-foot schooner across the Atlantic, then wandering the Mediterranean Sea) for a 9-hectare farm in Tresmonte complete with “an old stone house, several barns, an hórreo, the ex-boat cat, a dog, 2 donkeys, 5 horses, and 12 sheep,” as Barbara itemized in an email in 2019. My visit was action packed (of course), but one moment stands out to me. Did I want to see the secret caves in the hills behind her house? Did I?? And there I was, scrambling through underbrush, along vestiges of trails disappearing into mirage, but trusting Barbara to lead me to and through a crack in the rocks that revealed cavernous spaces replete with bats and graffiti dating back to refugees from the Spanish Civil War. Following Barbara into adventures, big or small, was to be categorically alive.

Ginny sums it up best, when she says, “Working at PLOS was the highlight of my professional life, and working with Barbara was one of the main reasons for that. In addition to her intense work ethic, she was kind and funny, and her passion for life was infectious.”

Or, as Bette concludes, “She was full bore on everything that she did. Barbara’s radical honesty, brilliance, curiosity about other people, vim and love of life was a potent, delightful mix. I will miss her.”

As will we all.

If you have memories of Barbara you’d like to share, please add them to the comments section below.

Discussion
  1. I am sorry to hear the sad news. I first met Barbara when she interviewed at Nature in 1994. It was clear within the first few minutes of her interview that she was a dynamo, and it was a no-brainer that she would be offered the job. Later, when Nature Genetics moved to New York in 1997, she and I both interviewed for the role of chief editor. They wisely chose Barbara, who knew much more genetics than I did, but we became close colleagues after I was appointed to Nat Neurosci and joined her in NYC a few months later. Nat Gen was already well established, but it went from strength to strength under Barbara’s leadership. This was a time of dramatic advance, culminating in the first human genome sequence in 2000, and Barbara’s intellect and energy ensured that NG remained at the forefront of the genomics revolution. After she left Nature for PLOS, we became friendly competitors but continued to meet socially, in NY and later in California. I believe we last met at Sandra’s and Ken’s house in Winters CA, on New Year’s Day 2011. My daughter Claire had just turned 5, and while the rest of us were nursing our hangovers, I remember Barbara taking Claire outside and sprinting together down the Californian hillside through the long grass, as an expression of transgenerational girl power!
    My condolences to Barbara’s friends and family – she will be missed.

    Charles Jennings

  2. This is really sad news. Barbara has a special place in PLOS’ history and I send condolences to her friends and family. (And thanks to Hemai for the fitting tribute.)

  3. How sad. I have the fondest memory of Barbara, both when she worked with me as an undergrad in Herbert Jäckle’s lab, and then later at Nature and PLoS. I was just talking on Sunday to a common friend from the 80s about Barbara. My condolences to her friends and family. Thank you for this article.

  4. Beautiful tribute Hemai.

    Barbara was a such force of Nature. I came to Nature in 96 thinking Kevin Davies and Nature Genetics were one and the same and that it would always be so… But Barbara quickly changed that misconception. What an intellect. And what a visionary. A truly inspirational editor. And lets not forget no fool suffered! I loved how she roasted the publishing types who came over from London with their fancy ideas. Barbara would never shy from a fight. No fear of speaking truth to power. And such a great advocate for upholding the editorial standards in the face of commercial pressures. Delphine and I have very happy memories of going over to her and Phil Bernstein’s place in Brooklyn. Thinking of all her family and friends.

  5. It was such a shock to hear of Barbara’s tragic passing.

    She and I had many fun conversations in the late ‘90s after I’d returned to Nature and, from her position heading Nature Genetics, she played an important role helping us in the flagship to develop stronger relationships with the Human Genome Project. I lost touch with her after she moved away from science publishing until, last year, after I retired, she got in touch in a characteristically enthusiastic style, with pictures of Asturias, and invited me to visit. I was looking forward to seeing her next year.

    Thanks for your memories above. They not only celebrate Barbara’s great professional strengths and achievements, but also duly highlight this exceptionally positive and adventurous person.

  6. It is a really lovely tribute Hemai – thank you. I have such vivid memories of Barbara from our days together at PLOS – her passion, her laughter, her wicked sense of humour, her scary intelligence, her ferocious anger (especially at any injustice) and equally ferocious compassion and kindness. She could hug like a bear. The tragedy of her premature death is made so much more acute by the way she embraced all aspects of life. She loved science and was deeply committed to reforming how science was communicated (and evaluated), but I also remember her turning up on her big honda motorbike, drinking whiskey and singing Schubert songs in German to me, and being an incredibly generous host. She was both deadly serious and enormous fun – and always always authentic. I was incredibly fortunate to know her and learn from her. I just wish I had taken up her invitation to visit her and Jim in Spain. Life is too short. My heartfelt condolences to all her family and friends.

  7. Barbara inspired a lot of the work I did for PLOS. It was more than her commitment and dedication to the PLOS and the OA movement. She told me stories about how she would be at a PLOS booth at a conference and corner researchers walking in the aisles to tell them about OA and why they should publish with PLOS. If you knew Babara, you could see her doing that, and let me tell you that you would not be able to pass until you heard her pitch. I will admit, when you first met Barbara, she was very intimidating, especially to me, since I had no background in science, research, or academia. Still, she was open to debate and listened, and if you convinced her, she would support you.

    PLOS will always be a bright spot in my working career, mainly because of the company culture. Barbara and some of the other founding editors set a work cultural tone by starting Wine Fridays, fondly known as WiFri. In the beginning, everyone put a little money in a box so we could buy a few bottles of wine. One day the box disappeared and when I asked Barbara who do I pay she said it was taken care of. I later learned that Barbara and others used their honorariums from speaking engagements to buy better wine and share them with everyone on staff.

    It was those WiFri that allowed me to get to know Barbara better and see her zest for life, and her “all in” mindset. After she left PLOS, a few of us would meet up, and she would talk about her sailing adventures, show pictures of the cat in a hammock, and photos of hundreds of dolphins swimming next to their boat. We then heard stories of her living in Vallejo, flipping houses, and moving to Spain with all her animals.

    Thank you, Barbara, for inspiring me at work and in life. May we all live with an “all in” mindset. So, a gratitude toast to you. Happy WiFri! Miss you dearly.

  8. I had the honour and privilege of working with Barbara at Nature Genetics. As a colleague and as a friend, Barbara was courageous, funny, adventurous and full of integrity and energy. She had the trust of the scientific community, colleagues, and friends because she was exactly as she appeared – her true self always. In times of uncertainty, you knew she had your back. I’m struggling to accept that this world has lost her infectious energy and vibrant smile.

Leave a Reply

Your email address will not be published. Required fields are marked *


Add your ORCID here. (e.g. 0000-0002-7299-680X)

Related Posts
Back to top